Francisco J Flores-Ramirez1, Lyonna F Parise2, Jason B Alipio3, Israel Garcia-Carachure4, Samuel A Castillo4, Minerva Rodriguez4, Anapaula Themman4, Omar Lira4, Joshua Preciado-Piña4, Sergio D Iñiguez5. 1. Department of Psychology, The University of Texas at El Paso, El Paso, TX, USA; Department of Psychology, California State University, San Bernardino, CA, USA. 2. Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Department of Psychology, California State University, San Bernardino, CA, USA. 4. Department of Psychology, The University of Texas at El Paso, El Paso, TX, USA. 5. Department of Psychology, The University of Texas at El Paso, El Paso, TX, USA; Department of Psychology, California State University, San Bernardino, CA, USA. Electronic address: sdiniguez@utep.edu.
Abstract
BACKGROUND: Epidemiological reports indicate that mood-related disorders are common in the adolescent population. The prevalence of juvenile major depressive disorder has resulted in a parallel increase in the prescription rates of fluoxetine (FLX) within this age group. Although such treatment can last for years, little is known about the enduring consequences of adolescent antidepressant exposure on memory-related performance. METHODS: We exposed separate groups of adolescent (postnatal day [PD] 35) male and female C57BL/6 mice to FLX (20 mg/kg) for 15 consecutive days (PD35-49). Three weeks after FLX exposure (PD70), we assessed learning and memory performance on a single-day training object novelty recognition test, or a spatial memory task on the Morris water maze (MWM). RESULTS: We found that FLX pretreatment did not influence performance on either the object novelty recognition task or the MWM, 24 h after training. Conversely, 48 h post spatial-training on the MWM, FLX pretreated male mice spent significantly less time on the quadrant of the missing platform during a standard probe trial. No differences in MWM performance were observed in the adult female mice pretreated with FLX. LIMITATIONS: A limitation of this study is that normal adolescent mice (i.e., non-stressed) were evaluated for memory-related behavior three weeks after antidepressant exposure. Thus, it is possible that FLX pre-exposure in combination with animal models for the study of depression may yield different results. CONCLUSION: Together, these results demonstrate enduring spatial memory-related deficiencies after pre-exposure to FLX during adolescence in male, but not female, C57BL/6 mice.
BACKGROUND: Epidemiological reports indicate that mood-related disorders are common in the adolescent population. The prevalence of juvenile major depressive disorder has resulted in a parallel increase in the prescription rates of fluoxetine (FLX) within this age group. Although such treatment can last for years, little is known about the enduring consequences of adolescent antidepressant exposure on memory-related performance. METHODS: We exposed separate groups of adolescent (postnatal day [PD] 35) male and female C57BL/6 mice to FLX (20 mg/kg) for 15 consecutive days (PD35-49). Three weeks after FLX exposure (PD70), we assessed learning and memory performance on a single-day training object novelty recognition test, or a spatial memory task on the Morris water maze (MWM). RESULTS: We found that FLX pretreatment did not influence performance on either the object novelty recognition task or the MWM, 24 h after training. Conversely, 48 h post spatial-training on the MWM, FLX pretreated male mice spent significantly less time on the quadrant of the missing platform during a standard probe trial. No differences in MWM performance were observed in the adult female mice pretreated with FLX. LIMITATIONS: A limitation of this study is that normal adolescent mice (i.e., non-stressed) were evaluated for memory-related behavior three weeks after antidepressant exposure. Thus, it is possible that FLX pre-exposure in combination with animal models for the study of depression may yield different results. CONCLUSION: Together, these results demonstrate enduring spatial memory-related deficiencies after pre-exposure to FLX during adolescence in male, but not female, C57BL/6 mice.
Authors: Yael Abreu-Villaça; Cláudio Carneiro Filgueiras; Monique Guthierrez; Ana Heloisa de Medeiros; Maria Angélica Mattos; Maurício Dos Santos Pereira; Alex Christian Manhães; Regina Célia Cussa Kubrusly Journal: Nicotine Tob Res Date: 2010-05-10 Impact factor: 4.244
Authors: Sebastian Jessberger; Robert E Clark; Nicola J Broadbent; Gregory D Clemenson; Antonella Consiglio; D Chichung Lie; Larry R Squire; Fred H Gage Journal: Learn Mem Date: 2009-01-29 Impact factor: 2.460
Authors: Leslie R Amodeo; Venuz Y Greenfield; Danielle E Humphrey; Veronica Varela; Joseph A Pipkin; Shannon E Eaton; Jelesa D Johnson; Christopher P Plant; Zachary R Harmony; Li Wang; Cynthia A Crawford Journal: Psychopharmacology (Berl) Date: 2015-07-05 Impact factor: 4.530
Authors: Georgia E Hodes; Tiffany E Hill-Smith; Raymond F Suckow; Thomas B Cooper; Irwin Lucki Journal: J Pharmacol Exp Ther Date: 2009-10-14 Impact factor: 4.030
Authors: Francisco J Flores-Ramirez; Israel Garcia-Carachure; David O Sanchez; Celene Gonzalez; Samuel A Castillo; Miguel A Arenivar; Anapaula Themann; Omar Lira; Minerva Rodriguez; Joshua Preciado-Piña; Sergio D Iñiguez Journal: J Psychopharmacol Date: 2018-10-18 Impact factor: 4.153
Authors: Quincey LaPlant; Vincent Vialou; Herbert E Covington; Dani Dumitriu; Jian Feng; Brandon L Warren; Ian Maze; David M Dietz; Emily L Watts; Sergio D Iñiguez; Ja Wook Koo; Ezekiell Mouzon; William Renthal; Fiona Hollis; Hui Wang; Michele A Noonan; Yanhua Ren; Amelia J Eisch; Carlos A Bolaños; Mohamed Kabbaj; Guanghua Xiao; Rachael L Neve; Yasmin L Hurd; Ronald S Oosting; Gouping Fan; John H Morrison; Eric J Nestler Journal: Nat Neurosci Date: 2010-08-22 Impact factor: 24.884
Authors: Israel Garcia-Carachure; Francisco J Flores-Ramirez; Samuel A Castillo; Anapaula Themann; Miguel A Arenivar; Joshua Preciado-Piña; Arturo R Zavala; Mary Kay Lobo; Sergio D Iñiguez Journal: Neuropsychopharmacology Date: 2020-03-12 Impact factor: 7.853
Authors: Daniela Franco; Jennifer Zamudio; Kennedy M Blevins; Eric A Núñez-Larios; Ulises M Ricoy; Sergio D Iñiguez; Arturo R Zavala Journal: Behav Brain Res Date: 2020-04-30 Impact factor: 3.332
Authors: Francisco J Flores-Ramirez; Anapaula Themann; Jorge A Sierra-Fonseca; Israel Garcia-Carachure; Samuel A Castillo; Minerva Rodriguez; Omar Lira; Joshua Preciado-Piña; Brandon L Warren; Alfred J Robison; Sergio D Iñiguez Journal: Sci Rep Date: 2021-04-08 Impact factor: 4.996